Abstract
Terminology value sets are central to research studies using real-world patient data. We describe the considerable challenges that arise when researchers develop value sets for their studies or reuse those made by others. We present Value Set Hub (VS-Hub), software to overcome these challenges, describing its design, implementation, features, use in the field, lessons learned, and future directions. Over a five-month period, VS-Hub has been used by over 200 users and has been used in the development and curation of 95 recommended value sets for commonly studied conditions, treatments, and lab tests. Particular innovations include the presentation of multiple value sets on the same screen for easy comparison, the display of compared value sets in the context of vocabulary hierarchies, the integration of these analytic features and value set authoring, and value set browsing features that encourage users to review existing value sets that may be relevant to their needs.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the National Institutes of Health (NIH) Agreement OT2HL161847 01 and NCATS U24 TR002306.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
